CONMED Corp — Director's Dealing 2013

Feb 20, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-02-19

Reporting Person: JONAS DANIEL (VP Legal Affairs, Gen. Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-19	Common Stock	M	8000	$26.69	Acquired	15223	Direct
2013-02-19	Common Stock	F	7328	$30.74	Disposed	7895	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-19	Sars (Stock Appreciation Rights)	$26.69	M	8000	Disposed	2018-06-01	Common Stock (8000)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal
amounts over a five year period.